Avail Investment Partners »

Regeneron Pharmaceuticals shares owned by Avail Investment Partners

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Avail Investment Partners from 13F filings

Historical chart of Avail Investment Partners investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Avail Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Avail Investment Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $202k 261 773.95

More positions owned by Avail Investment Partners

NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Shrt Nat Mun Etf (SUB)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Msci Acwi Ex Us (ACWX)
Abrdn Etfs Bbrg All Comd K1 (BCI)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Ishares Tr Core 1 5 Yr Usd (ISTB)
Ishares Tr National Mun Etf (MUB)
Apple (AAPL)
Ishares Tr Core High Dv Etf (HDV)
United Parcel Service CL B (UPS)
Ishares Tr Ibonds Dec 27 (IBMP)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)

View all positions for Avail Investment Partners

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
Vanguard Capital Management
State Street Corporation
Dodge & Cox
Franklin Resources
Geode Capital Management
FMR
Nuveen
Loomis, Sayles and
Invesco
Vanguard Portfolio Management
Goldman Sachs Group
Capital World Investors
Susquehanna International

View all funds holding Regeneron Pharmaceuticals